The best Bull and Bear pitches based on recency and number of recommendations.
My disastrous flirtation with FibroCell tells me I don't know much about the market for cosmetic therapies, but I'll hazard a green thumb on Kythera ahead of the topline data from the phase III trials of ATX-101 in chin fat. The two European phase… More
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about KYTH.DL.
Find the members with the highest scoring picks in KYTH.DL.
See what the Wall Street professionals think, according to their public statements and filings.